Close

StemCells (STEM) Posts Q3 Loss of $0.31, Sales Top Expectations

November 1, 2011 4:58 PM EDT
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.31), $0.14 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $224 thousand versus the consensus estimate of $210 thousand.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings